GRPR-targeting radiotheranostics for breast cancer management

Breast Cancer (BC) is the most common cancer worldwide and, despite the advancements made toward early diagnosis and novel treatments, there is an urgent need to reduce its mortality. The Gastrin-Releasing Peptide Receptor (GRPR) is a promising target for the development of theranostic radioligands...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Onofrio, Alice, Engelbrecht, Swantje, Läppchen, Tilman, Rominger, Axel, Gourni, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657217/
https://www.ncbi.nlm.nih.gov/pubmed/38020178
http://dx.doi.org/10.3389/fmed.2023.1250799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10657217/
https://www.ncbi.nlm.nih.gov/pubmed/38020178
http://dx.doi.org/10.3389/fmed.2023.1250799

Ejemplares similares